PortfoliosLab logoPortfoliosLab logo

Fidelity Disruptive Medicine ETF (FMED) Alternatives

Fidelity Disruptive Medicine ETF (FMED) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with FMED. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.

Cheapest Alternatives to FMED

FMED charges 0.50% annually. Among ETFs in the Health & Biotech Equities category, these options have the lowest expense ratios among FMED alternatives.


Best Risk-Adjusted Alternatives to FMED

Among ETFs in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.


Top Performing FMED Alternatives (YTD)

FMED alternatives from the Health & Biotech Equities category, sorted by year-to-date return.


Lowest Volatility Alternatives to FMED

FMED alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.


Lowest Drawdown Alternatives to FMED

FMED alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.


Other ETFs from Fidelity

Most popular Fidelity ETFs on PortfoliosLab, across asset classes.


Often Compared With FMED

What investors most often compare with FMED, based on PortfoliosLab usage data.


Compare FMED with Any Fund or Stock

Compare FMED with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


Fidelity Disruptive Medicine ETF